Back Login to subscribe 🔔 Set Alert

IRMD iRadimed Corporation Common Stock

15 min delay

Loading...

Loading...

Loading...

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est	63.55%
	iRadimed Affirms FY2026 Adj EPS Guidance of $2.06-$2.21 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $92.346M Est	60.29%
	iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est	47.43%
	iRadimed Sees Q2 Adj EPS $0.44-$0.48 vs $0.47 Est; Sees Sales $20.000M-$21.000M vs $21.134M Est	75.08%
	iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate	94.76%
	Earnings Scheduled For May 1, 2026	91.4%